Seekin Inc.’s cancer mutation detection kit Pancanseek for leukemia patients has received a CE-IVD mark, expanding the company’s reach in the testing space. This kit uses high-depth whole-genome ...
BEIJING, April 19, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in ...
Show More Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan; Graduate School of Engineering Science, Osaka University, Osaka, Japan; Osaka International Cancer ...
Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, today announced the launch of its first ultrasensitive multiplexed digital PCR assay, the ddPLEX ...
Markets Insider and Business Insider Editorial Teams were not involved in the creation of this post. Genetron Holdings NewsMORE Indices Commodities Currencies Stocks ...
It can assess patients’ suitability for Amgen’s colorectal cancer drug, Vectibix. Canadian regulatory authorities approved DxS’ TheraScreen K-RAS Mutation Kit for use as a diagnostic for anti-EGFR ...
SHENZHEN, China, Dec. 19, 2022 /PRNewswire/ -- SeekIn Inc, a leader in blood-based cancer early detection and monitoring technology, today announced CE (Conformité Européenne) Mark approval for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results